University of California, San Francisco — Clinical Trial Pipeline

University of California, San Francisco has 10 registered trials in the index.

Trials (10)

• Improving Cognition and Behavior in Pediatric Cancer Survivors Using a Novel Mindful Attention Training N/A · University of California, San Francisco
• Pragmatic Research of Acupuncture and Counseling eXtended to Inpatient Services N/A · University of California, San Francisco
• Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma Phase 2 · University of California, San Francisco
• UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations N/A · University of California, San Francisco
• Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry) N/A · University of California, San Francisco
• Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery Phase 1/2 · University of California, San Francisco
• Predicting Cognitive Decline From Androgen Deprivation Therapy N/A · University of California, San Francisco
• Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT Phase 2 · University of California, San Francisco
• Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids N/A · University of California, San Francisco
• Herbal Therapy in Treating Women With Metastatic Breast Cancer Phase 1/2 · University of California, San Francisco

Related landscapes

• Pediatric Cancer
• Malignant Solid Tumor
• Pain
• Glioblastoma
• Gliosarcoma

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.